Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024

Amrutha S Alibilli   ^{1 *} ;   Vidur Jain   ^{1 *} ;   Heran Mane   ^{1 *} , BS ;   Xiaohe Yue   ¹ , MS ;   Alexandria Ratzki-Leewing   ^{2, 3 *} , MSc, PhD ;   Junaid S Merchant   ^{1 *} , MS, PhD ;   Shaniece Criss   ^{4 *} , MPH, MPA, SCD ;   Quynh C Nguyen   ^{5 *} , MSPH, PhD ;   Rozalina G McCoy   ^{2, 3, 6 *} , MS, MD ;   Thu T Nguyen   ^{1, 3 *} , MSPH, SCD

¹ Department of Epidemiology and Biostatistics, University of Maryland, College Park, College Park, United States

² Division of Gerontology, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, United States

³ University of Maryland Institute for Health Computing, North Bethesda, MD, United States

⁴ Department of Health Sciences, Furman University, Greenville, SC, United States

⁵ National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, United States

⁶ Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States

*these authors contributed equally